 Access to this symposium
requires KEY ZONE access (paid registration) to HDCN. For
information about subscribing to HDCN, please go to this
link. |
PART III
Presentation & Speakers |
Link |
Dry Weight – Neither More, Nor Less:
Online Assessment of ECV During Hemodialysis |
| Martin Kuhlmann, MD - Universitaetskliniken des Saarlandes; Homburg, Germany |
|
|
| Dry Weight Online Assessment of Rebound |
| Roger Greenwood, MD - Lister Hospital; Stevenage, United Kingdom |
|
| The Significance of Residual Renal Function – Is it the Pee or the Bean? |
| John Burkart, MD - Wake Forest University Medical Center; Winston-Salem, NC |
|
| Cardiovascular Disease Causes and Consequences of Sympathetic Hyperactivity in CKD |
| Peter Kotanko, MD - Renal Research Institute; New York, NY |
|
| CRITICAL ASSESSMENT A Critical Evaluation of PD as a Therapy |
| Norbert Lameire, MD - University Hospital Ghent; Ghent, Belgium |
|
KEYNOTE ADDRESS: CKD MANAGEMENT –
WHAT CAN WE LEARN FROM SOUTH AFRICAN & AUSTRALIAN EFFORTS? |
| Ivor J. Katz, MD - Dumisani Mzamane African Institute of Kidney Disease; Soweto, South Africa |
|
The NIH Daily and Nocturnal Dialysis Study; Full Disclosure! Q & A |
| Rita Suri, MD, FRCPC, FACP - University of Western Ontario; London, Canada |
|
SPECIAL DEBATE Carnitine is Valuable in Dialysis Patients
Brian Schreiber, MD (Yes) |
| Brian Schreiber, MD - Medical College of Wisconsin; Milwaukee, WI |
|
SPECIAL DEBATE Carnitine is Valuable in Dialysis Patients
Garry Handelman, PhD (No) |
| Garry Handelman, PhD - University of Massachusetts; Lowell, MA |
|
| New Important Technologies Oral Sorbents in Uremia: Early Results |
| Gerald Schulman, MD, FASN - Vanderbilt University School of Medicine; Nashville, TN |
|
| Proven Strategies to Reduce CV Mortality in HD Patients |
Hannelore Hampl, MD - University of Berlin; Berlin, Germany |
|
PART II
Presentation & Speakers |
Link |
| Disease Management Actually Works in Dialysis Patients |
| Jeffrey J. Sands, MD, MMM - Fresenius Medical Care; Lexington, MA USA |
|
|
| Hemodiafiltration (HDF) – A Critical Evaluation of its Value |
| Claudio Ronco, MD - St . Bortolo Hospital; Vicenza, Italy |
|
| Kidneys, Hearts, Hormones, Immunomodulators and More: Complex Systems Requiring Integrated Understandings |
| Adeera Levin, MD, FRCPC - University of British Columbia; Vancouver, Canada |
|
| Association Between Inflammation and Malnutrition as Risk Factors for CV Disease |
| Sanjay Rajagopalan, MD - Mount Sinai School of Medicine; New York, NY |
|
| KEYNOTE ADDRESS: SODIUM AS A UREMIC TOXIN |
| Eberhard Ritz, MD - Klinikum der Universitaet Heidelberg; Heidelberg, Germany |
|
| Uremia Uric Acid – A Uremic Toxin? |
| T. Alp Ikizler, MD - Vanderbilt University Medical Center; Nashville, TN |
|
Early Disease Detection via the Proteome |
| Ken Turtletaub, PhD - Lawrence Livermore National Laboratory; Livermore, CA |
|
| CRITICAL ASSESSMENT A Critical Evaluation of Uremic Research: Where Do We Go From Here? |
| Francesco Locatelli, MD - General Hospital; Lecco, Italy |
|
SPECIAL DEBATE Access Flow Monitoring is Worthwhile and Valuable
Anatole Besarab, MD (Yes) |
| Anatole Besarab, MD - Henry Ford Hospital; Detroit, MI |
|
SPECIAL DEBATE Access Flow Monitoring is Worthwhile and Valuable
Jack Work, MD (No) |
| Jack Work, MD - Emory University; Atlanta, GA |
|
| Uremia Uric Acid – A Uremic Toxin? |
| Takahiko Nakagawa, MD - University of Florida; Gainesville, FL |
|
| Vascular Access Evaluation of Fistulae and Grafts over Time – New Thoughts |
Arif Asif, MD - University of Miami Miller School of Medicine; Miami, FL |
|
PART I
Presentation & Speakers |
Link |
| Dialyzer & Machine Technologies; New Applications in Practice |
| Richard A Ward, MD - University of Louisville; Louisville, KY |
|
|
| The Importance of Water Treatment & Dialysate Composition |
| Nicholas A. Hoenich, PhD - University of Newcastle; Newcastle upon Tyne, United Kingdom |
|
| Prevention of Medical Errors in Dialysis: Design & Implementation Strategies |
| Alan S. Kliger, MD - Hospital of St. Raphael; Yale University School of Medicine New Haven, CT |
|
| How to Set up and Run a Successful PD Program |
| Jose A. Diaz-Buxo, MD, FACP - Fresenius Medical Care; Lexington, MA |
|
| A View of Dialysis from a Nurse Practitioner |
| Seth Johnson, NP - Beth Israel Medical Center; New York, NY |
|
| Understanding the Finances of a Dialysis Facility |
| Peter B. De Oreo, MD - Centers of Dialysis Care; Cleveland, OH |
|
| Payment for Performance |
| Richard Goldman, MD - Renal Medicine Associates; Albuquerque, NM |
|
Implications for Survey and Certification of Dialysis Facilities.
Composite Rate Medicare Modernization Act (MMA)
Update: Adjusted Case Mix Demonstration Project |
| Barry Straube, MD - Centers for Medicare & Medicaid Services; Baltimore, MD |
|
| What is Now Expected from Medical Directors of Dialysis Units? |
| Robert Provenzano, MD- St . John Hospital & Medical Center; Detroit, MI |
|
| Dialysis Kinetics: Q & A |
| Frank Gotch, MD - Consultant FMC and Renal Research Institute, San Francisco, CA |
|
|
|
